These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22398291)

  • 1. Attenuated influenza virus construct with enhanced hemagglutinin protein expression.
    Maamary J; Pica N; Belicha-Villanueva A; Chou YY; Krammer F; Gao Q; García-Sastre A; Palese P
    J Virol; 2012 May; 86(10):5782-90. PubMed ID: 22398291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza.
    Steel J; Lowen AC; Pena L; Angel M; Solórzano A; Albrecht R; Perez DR; García-Sastre A; Palese P
    J Virol; 2009 Feb; 83(4):1742-53. PubMed ID: 19073731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
    Choi EH; Song MS; Park SJ; Pascua PN; Baek YH; Kwon HI; Kim EH; Kim S; Jang HK; Poo H; Kim CJ; Choi YK
    Arch Virol; 2015 Jul; 160(7):1729-40. PubMed ID: 25959557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-clade protective immune responses of NS1-truncated live attenuated H5N1 avian influenza vaccines.
    Shi S; Chen S; Han W; Wu B; Zhang X; Tang Y; Wang X; Zhu Y; Peng D; Liu X
    Vaccine; 2016 Jan; 34(3):350-7. PubMed ID: 26638027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Modulation of Innate Immune Responses in Human Primary Cells by Influenza A Viruses Carrying Human or Avian Nonstructural Protein 1.
    Monteagudo PL; Muñoz-Moreno R; Fribourg M; Potla U; Mena I; Marjanovic N; Hartmann BM; Sealfon SC; García-Sastre A; Ramos I; Fernández-Sesma A
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
    Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors.
    Panaampon J; Ngaosuwankul N; Suptawiwat O; Noisumdaeng P; Sangsiriwut K; Siridechadilok B; Lerdsamran H; Auewarakul P; Pooruk P; Puthavathana P
    PLoS One; 2012; 7(5):e36318. PubMed ID: 22563489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Evolution of the 2009 Pandemic H1N1 Influenza Virus NS1 and PA in Humans.
    Nogales A; Martinez-Sobrido L; Chiem K; Topham DJ; DeDiego ML
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development.
    Nogales A; Baker SF; Ortiz-Riaño E; Dewhurst S; Topham DJ; Martínez-Sobrido L
    J Virol; 2014 Sep; 88(18):10525-40. PubMed ID: 24965472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.
    Nogales A; DeDiego ML; Topham DJ; Martínez-Sobrido L
    J Virol; 2016 Jul; 90(14):6291-6302. PubMed ID: 27122587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C terminus of NS1 protein of influenza A/WSN/1933(H1N1) virus modulates antiviral responses in infected human macrophages and mice.
    Anastasina M; Schepens B; Söderholm S; Nyman TA; Matikainen S; Saksela K; Saelens X; Kainov DE
    J Gen Virol; 2015 Aug; 96(8):2086-2091. PubMed ID: 25934792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Promising IFN-Deficient System to Manufacture IFN-Sensitive Influenza Vaccine Virus.
    Chen C; Fan W; Li J; Zheng W; Zhang S; Yang L; Liu D; Liu W; Sun L
    Front Cell Infect Microbiol; 2018; 8():127. PubMed ID: 29765910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein.
    Zielecki F; Semmler I; Kalthoff D; Voss D; Mauel S; Gruber AD; Beer M; Wolff T
    J Virol; 2010 Oct; 84(20):10708-18. PubMed ID: 20686040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).
    Gambaryan AS; Lomakina NF; Boravleva EY; Kropotkina EA; Mashin VV; Krasilnikov IV; Klimov AI; Rudenko LG
    Influenza Other Respir Viruses; 2012 May; 6(3):188-95. PubMed ID: 21951678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H5N1 influenza A virus with K193E and G225E double mutations in haemagglutinin is attenuated and immunogenic in mice.
    Han PF; Li J; Hu Y; Sun W; Zhang S; Yang YH; Li YC; Kang XP; Wu XY; Zhu SY; Zhang Y; Zhu QY; Qin CF; Jiang T
    J Gen Virol; 2015 Sep; 96(9):2522-2530. PubMed ID: 25998916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nuclear NS1 protein in highly pathogenic H5N1 influenza viruses.
    Mok BW; Liu H; Chen P; Liu S; Lau SY; Huang X; Liu YC; Wang P; Yuen KY; Chen H
    Microbes Infect; 2017 Dec; 19(12):587-596. PubMed ID: 28903072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.